SINGAPORE (Reuters) - Virtual currency bitcoin dipped slightly from the previous session's record highs on Tuesday, after a month of whirlwind and volatile gains leading up to the launch of bitcoin futures on the weekend.
WASHINGTON (Reuters) - President Donald Trump's campaign to shrink the "bloated federal bureaucracy" so far has made a small dent in the federal workforce, and that largely because of a decline in civilian defense jobs.
SYDNEY/MELBOURNE (Reuters) - Unibail-Rodamco, Europe's biggest property group, has agreed to buy shopping mall owner Westfield Corp for $16 billion, marking the biggest takeover of an Australian company and a shift in global retail property to counter online shopping.
(Reuters) - The Dow Jones Industrial Average was set to open higher on Tuesday on gains from oil-related stocks and Boeing, while the S&P 500 and the Nasdaq futures pointed to a flat opening ahead of the Federal Reserve's policy meeting.
(Reuters) - Comcast Corp said on Monday it had abandoned its bid for most of the assets of Rupert Murdoch’s Twenty-First Century Fox Inc, leaving Walt Disney Co as the sole suitor in pursuit of the $40 billion-plus deal.
SEATTLE (Reuters) - PepsiCo Inc has reserved 100 of Tesla Inc's new electric Semi trucks, the largest-known order of the big rig, as the maker of Mountain Dew soda and Doritos chips seeks to reduce fuel costs and fleet emissions, a company executive said on Tuesday.
LONDON (Reuters) - The British Labour Party's would-be finance minister, John McDonnell, has accepted an invitation for talks at the Wall Street bank Goldman Sachs as it seeks better relations with a political party whose leaders have pilloried bankers.
HAMBURG/BERLIN (Reuters) - Germany's KBA automotive watchdog on Tuesday announced a recall of Volkswagen's flagship European sport-utility vehicles (SUV) with 3-litre diesel engines after detecting two illicit emissions control devices in the models.
PARIS (Reuters) - Sanofi still needs to convince markets it can deliver on an exciting and sustainable growth path as it contends with fresh difficulties in its vaccines arm and looks set for another gloomy year in diabetes, investors told Reuters.